BARDA highlights Tiba in a new FASTx program to accelerate the development of early-stage antiviral platforms with multiple collaborators
Christian Mandl delivers a presentation on the past, and future, of mRNA vaccines at the GVIRF 2021
February 23, 2021
Tiba’s co-founder and mRNA visionary, Christian Mandl, spoke at the Global Vaccine and Immunization Research Forum 2021, the central forum for research related to the Immunization Agenda 2030 (IA2030). GVIRF is the only global meeting that brings together the entire Vaccine and Immunization Research community, from basic immunology to implementation research, and from low to high income countries.
Keep connected with us
© 2024 Tiba Biotech LLC. All rights reserved